MedTrace Logo

Evaluation of Apaisant Serum - Ingrown Nails for Ingrown Toenails

NCT07041047 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-06-27

No results posted yet for this study

Summary

To open-label clinical study aims to evaluate the efficacy and safety of APAISANT SERUM - INGROWN NAILS, a Class IIa CE-marked medical device, in relieving pain and discomfort associated with inflamed ingrown nails. The study includes 22 subjects with ingrown nails at stage 1 or 2, who will apply the product twice daily for 7 days. The primary objective is to assess the reduction of pain using a Numerical Rating Scale (NRS, 0-10). Secondary objectives include assessing discomfort, inflammation, and overall symptom improvement. The study also evaluates investigator and patient global assessments, tolerance, and acceptability of the product. Safety will be monitored through clinical assessments and the collection of adverse events.

Conditions

  • Ingrown Toenails
  • Ingrown Nail Inflammation

Interventions

DEVICE

APAISANT SERUM - INGROWN NAILS

Topical application of APAISANT SERUM - INGROWN NAILS twice daily for 7 days.

Sponsors & Collaborators

  • Swiss Footcare Laboratories - Poderm Professional

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-27
Primary Completion
2024-08-20
Completion
2024-08-20

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07041047 on ClinicalTrials.gov